Functional Genomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512241636

Publication Date:

December 11, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Functional Genomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Functional Genomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Functional Genomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Functional Genomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Functional Genomics include Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA and MRM Proteomics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Functional Genomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Functional Genomics by region & country, by Type, and by Application.
The Functional Genomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Genomics.
Market Segmentation
By Company
Agilent Technologies, Inc.
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
(Integrated DNA Technologies, Inc.)
Exact Sciences Corporation
Hoffmann-La Roche Ltd
Illumina, Inc.
Merck KGaA
MRM Proteomics
Pacific Biosciences of California, Inc.
Promega Corporation
QIAGEN
Thermo Fisher Scientific Inc.
Segment by Type:
Kits & Assays
Instruments
Assays
Segment by Application
Transcriptomics
Epigenomics
Proteomics
Metabolomics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Functional Genomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Functional Genomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Functional Genomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Functional Genomics Product Introduction
1.2 Global Functional Genomics Market Size Forecast
1.3 Functional Genomics Market Trends & Drivers
1.3.1 Functional Genomics Industry Trends
1.3.2 Functional Genomics Market Drivers & Opportunity
1.3.3 Functional Genomics Market Challenges
1.3.4 Functional Genomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Functional Genomics Players Revenue Ranking (2023)
2.2 Global Functional Genomics Revenue by Company (2019-2024)
2.3 Key Companies Functional Genomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Functional Genomics Product Offered
2.5 Key Companies Time to Begin Mass Production of Functional Genomics
2.6 Functional Genomics Market Competitive Analysis
2.6.1 Functional Genomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Functional Genomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Genomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Kits & Assays
3.1.2 Instruments
3.1.3 Assays
3.2 Global Functional Genomics Sales Value by Type
3.2.1 Global Functional Genomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Functional Genomics Sales Value, by Type (2019-2030)
3.2.3 Global Functional Genomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Transcriptomics
4.1.2 Epigenomics
4.1.3 Proteomics
4.1.4 Metabolomics
4.2 Global Functional Genomics Sales Value by Application
4.2.1 Global Functional Genomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Functional Genomics Sales Value, by Application (2019-2030)
4.2.3 Global Functional Genomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Functional Genomics Sales Value by Region
5.1.1 Global Functional Genomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Functional Genomics Sales Value by Region (2019-2024)
5.1.3 Global Functional Genomics Sales Value by Region (2025-2030)
5.1.4 Global Functional Genomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Functional Genomics Sales Value, 2019-2030
5.2.2 North America Functional Genomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Functional Genomics Sales Value, 2019-2030
5.3.2 Europe Functional Genomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Functional Genomics Sales Value, 2019-2030
5.4.2 Asia Pacific Functional Genomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Functional Genomics Sales Value, 2019-2030
5.5.2 South America Functional Genomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Functional Genomics Sales Value, 2019-2030
5.6.2 Middle East & Africa Functional Genomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Functional Genomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Functional Genomics Sales Value
6.3 United States
6.3.1 United States Functional Genomics Sales Value, 2019-2030
6.3.2 United States Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Functional Genomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Functional Genomics Sales Value, 2019-2030
6.4.2 Europe Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Functional Genomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Functional Genomics Sales Value, 2019-2030
6.5.2 China Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Functional Genomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Functional Genomics Sales Value, 2019-2030
6.6.2 Japan Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Functional Genomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Functional Genomics Sales Value, 2019-2030
6.7.2 South Korea Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Functional Genomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Functional Genomics Sales Value, 2019-2030
6.8.2 Southeast Asia Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Functional Genomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Functional Genomics Sales Value, 2019-2030
6.9.2 India Functional Genomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Functional Genomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Profile
7.1.2 Agilent Technologies, Inc. Main Business
7.1.3 Agilent Technologies, Inc. Functional Genomics Products, Services and Solutions
7.1.4 Agilent Technologies, Inc. Functional Genomics Revenue (US$ Million) & (2019-2024)
7.1.5 Agilent Technologies, Inc. Recent Developments
7.2 Becton, Dickinson and Company (BD)
7.2.1 Becton, Dickinson and Company (BD) Profile
7.2.2 Becton, Dickinson and Company (BD) Main Business
7.2.3 Becton, Dickinson and Company (BD) Functional Genomics Products, Services and Solutions
7.2.4 Becton, Dickinson and Company (BD) Functional Genomics Revenue (US$ Million) & (2019-2024)
7.2.5 Becton, Dickinson and Company (BD) Recent Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Profile
7.3.2 Bio-Rad Laboratories, Inc. Main Business
7.3.3 Bio-Rad Laboratories, Inc. Functional Genomics Products, Services and Solutions
7.3.4 Bio-Rad Laboratories, Inc. Functional Genomics Revenue (US$ Million) & (2019-2024)
7.3.5 (Integrated DNA Technologies, Inc.) Recent Developments
7.4 (Integrated DNA Technologies, Inc.)
7.4.1 (Integrated DNA Technologies, Inc.) Profile
7.4.2 (Integrated DNA Technologies, Inc.) Main Business
7.4.3 (Integrated DNA Technologies, Inc.) Functional Genomics Products, Services and Solutions
7.4.4 (Integrated DNA Technologies, Inc.) Functional Genomics Revenue (US$ Million) & (2019-2024)
7.4.5 (Integrated DNA Technologies, Inc.) Recent Developments
7.5 Exact Sciences Corporation
7.5.1 Exact Sciences Corporation Profile
7.5.2 Exact Sciences Corporation Main Business
7.5.3 Exact Sciences Corporation Functional Genomics Products, Services and Solutions
7.5.4 Exact Sciences Corporation Functional Genomics Revenue (US$ Million) & (2019-2024)
7.5.5 Exact Sciences Corporation Recent Developments
7.6 Hoffmann-La Roche Ltd
7.6.1 Hoffmann-La Roche Ltd Profile
7.6.2 Hoffmann-La Roche Ltd Main Business
7.6.3 Hoffmann-La Roche Ltd Functional Genomics Products, Services and Solutions
7.6.4 Hoffmann-La Roche Ltd Functional Genomics Revenue (US$ Million) & (2019-2024)
7.6.5 Hoffmann-La Roche Ltd Recent Developments
7.7 Illumina, Inc.
7.7.1 Illumina, Inc. Profile
7.7.2 Illumina, Inc. Main Business
7.7.3 Illumina, Inc. Functional Genomics Products, Services and Solutions
7.7.4 Illumina, Inc. Functional Genomics Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina, Inc. Recent Developments
7.8 Merck KGaA
7.8.1 Merck KGaA Profile
7.8.2 Merck KGaA Main Business
7.8.3 Merck KGaA Functional Genomics Products, Services and Solutions
7.8.4 Merck KGaA Functional Genomics Revenue (US$ Million) & (2019-2024)
7.8.5 Merck KGaA Recent Developments
7.9 MRM Proteomics
7.9.1 MRM Proteomics Profile
7.9.2 MRM Proteomics Main Business
7.9.3 MRM Proteomics Functional Genomics Products, Services and Solutions
7.9.4 MRM Proteomics Functional Genomics Revenue (US$ Million) & (2019-2024)
7.9.5 MRM Proteomics Recent Developments
7.10 Pacific Biosciences of California, Inc.
7.10.1 Pacific Biosciences of California, Inc. Profile
7.10.2 Pacific Biosciences of California, Inc. Main Business
7.10.3 Pacific Biosciences of California, Inc. Functional Genomics Products, Services and Solutions
7.10.4 Pacific Biosciences of California, Inc. Functional Genomics Revenue (US$ Million) & (2019-2024)
7.10.5 Pacific Biosciences of California, Inc. Recent Developments
7.11 Promega Corporation
7.11.1 Promega Corporation Profile
7.11.2 Promega Corporation Main Business
7.11.3 Promega Corporation Functional Genomics Products, Services and Solutions
7.11.4 Promega Corporation Functional Genomics Revenue (US$ Million) & (2019-2024)
7.11.5 Promega Corporation Recent Developments
7.12 QIAGEN
7.12.1 QIAGEN Profile
7.12.2 QIAGEN Main Business
7.12.3 QIAGEN Functional Genomics Products, Services and Solutions
7.12.4 QIAGEN Functional Genomics Revenue (US$ Million) & (2019-2024)
7.12.5 QIAGEN Recent Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Profile
7.13.2 Thermo Fisher Scientific Inc. Main Business
7.13.3 Thermo Fisher Scientific Inc. Functional Genomics Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Inc. Functional Genomics Revenue (US$ Million) & (2019-2024)
7.13.5 Thermo Fisher Scientific Inc. Recent Developments
8 Industry Chain Analysis
8.1 Functional Genomics Industrial Chain
8.2 Functional Genomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Functional Genomics Sales Model
8.5.2 Sales Channel
8.5.3 Functional Genomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Agilent Technologies, Inc.
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
(Integrated DNA Technologies, Inc.)
Exact Sciences Corporation
Hoffmann-La Roche Ltd
Illumina, Inc.
Merck KGaA
MRM Proteomics
Pacific Biosciences of California, Inc.
Promega Corporation
QIAGEN
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂